NAPSR News: Actavis Announces 2014 Second Quarter Results

Actavis plc (NYSE: ACT) is a specialty pharmaceutical company specializing in developing, manufacturing and commercializing generic drugs and branded pharmaceutical products.



via Marketing - Latest News http://ift.tt/UWBXn1